Details of the Drug

General Information of Drug (ID: DM6GB6B)

• Drug Name: BMS-241027

Indication

Disease Entry	ICD 11	Status	REF
Alzheimer disease	8A20	Phase 1	[1]
Tauopathy	6D85.Y	Phase 1	[1]

• Cross-matching ID: TTD ID: D0V9HL
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] ClinicalTrials.gov (NCT01492374) Study to Evaluate the Safety, Tolerability and the Effect of BMS-241027 on Cerebrospinal Fluid Biomarkers in Subjects With Mild Alzheimer's Disease. U.S. National Institutes of Health.